BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview
Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 P/E Ratio

Latest P/E ratio for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028: 178.89 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

178.89

P/E Ratio

178.89

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest P/E ratio for AFJKR is 178.89. That is above the sector sector average of 22.73. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AFJKR currently prints 178.89 for P/E ratio, while the sector average sits near 22.73. That is roughly 686.9% above the sector mean. Large gaps often invite a closer look at Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's growth, margins, and balance sheet.

A P/E ratio of 178.89 for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 is not 'good' or 'bad' on its own. Compare it with the peer average (22.73) and with AFJKR's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting AFJKR's P/E ratio (178.89), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.